Navigation Links
Regado Biosciences to Present at the Rodman & Renshaw Global Investment Conference on September 10, 2009
Date:9/3/2009

BASKING RIDGE, N.J., Sept. 3 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the 11th Annual Healthcare Conference of the Rodman & Renshaw Global Investment Conference in New York, NY at 4:30 PM on Thursday, September 10, 2009 (EDT). Dr. Mazzo's presentation will include an overview of the Company's pipeline with emphasis on the lead development program, the anticoagulant system, REG1.

ABOUT REGADO BIOSCIENCES

Regado Biosciences is pioneering a new therapeutic technology with the creation and development of two-component drug systems. Each system comprises a nuclease-stabilized RNA aptamer that can be controlled directly by its specific and complementary oligonucleotide active control agent. This technology is being applied to injectable antithrombotics, including anticoagulants and antiplatelet agents, a multi-billion dollar market in need of therapeutics with improved safety profiles and a greater degree of therapeutic control. Regado's technology is designed to give physicians the ability to actively and directly control each system's therapeutic effect providing a safe and unique approach to personalized medicine.

ABOUT REG1

Regado's lead program, the anticoagulant system REG1, consists of two parenteral agents, the first being a potent highly selective Factor IXa inhibitor (RB006) and the second being its complementary active control agent (RB007). RB007 can be used to selectively completely or partially reverse the anticoagulant effect of RB006.

ABOUT APTAMERS

RB006 is a member of a class of compounds called aptamers. Aptamers are single stranded oligonucleotides that adopt a spec
'/>"/>

SOURCE Regado Biosciences
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Regado Biosciences REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis
2. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
3. Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
4. Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer
5. Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference
6. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
7. Regado Biosciences Establishes Medical Advisory Board
8. Regado Biosciences Expands Medical Advisory Board
9. Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... DIEGO , May 20, 2013  Dr. ... field of nucleic acid research, recently launched a new ... In with Zon ( zon.trilinkbiotech.com ), focuses on what,s ... include interviews with industry thought leaders, discussions of research ... and more. Dr. Zon (PhD Princeton ...
(Date:5/20/2013)... 20, 2013   Flexion Therapeutics , Inc. today ... to its management team as chief financial ... financial management experience with biotechnology and medical device companies. ... chief financial officer for Novavax (NASDAQ: NVAX ... than $250 million through a combination of investment funding ...
(Date:5/20/2013)... May 20, 2013 On 25-28 July, ... – in Paris - the beautiful city of lights. ... "Personalized Medicine is revolutionizing the medical world. Understanding and ... is the hallmark of this transformation. Much of the ... from the epidemiologic studies of large cohorts that do ...
(Date:5/19/2013)... Boston, MA (PRWEB) May 19, 2013 ... providing social media training online, has proudly announced that ... for small business has surpassed 175,000 views on YouTube. ... free social media and SEO tips and training for ... see my students find the YouTube tips helpful for ...
Breaking Biology Technology:Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2
... Alfacell Corporation (OTC Bulletin Board: ACEL) today reported ... U.S. Food and Drug Administration (FDA) to discuss the ... ONCONASE rolling New Drug Application (NDA) for the treatment ... pre-NDA meeting, the FDA provided guidance to the company ...
... PUBLISHED BY UNIVERSAL , NETTLETON, Miss., Jan. 27 ... that certain unauthorized inaccurate information is being published ... website, potentially other websites and publications, and an ... company has found errors in statements concerning the ...
... Scheduled for Tuesday, February 3, 2009 SAN DIEGO, Jan. ... ) announced today that the Company will report its ... Nasdaq market closes on Tuesday, February 3, 2009. Neurocrine ... to discuss its financial results and provide a Company ...
Cached Biology Technology:Alfacell Provides ONCONASE(R) NDA Submission Update 2Alfacell Provides ONCONASE(R) NDA Submission Update 3Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results 2
(Date:5/17/2013)... a group of proteins in the brain responsible for ... target that could increase cell survival. , The discovery, ... and published in the EMBO journal with ... new therapies for stroke and other brain diseases. , ... which identified a protein, known as SUMO, responsible for ...
(Date:5/17/2013)... An international team of scientists ... and cell movement inside a living frog embryo in ... new method to advance biological research and the search ... University and the Karlsruher Institut fr Technologie in Germany, ... U.S. Department of Energy,s Argonne National Laboratory, released the ...
(Date:5/16/2013)... ancient shorelines to predict the stability of today,s largest ice ... from three million years ago, for example when Earth ... be evidence of a high sea level due to ice ... scientists to think that if the world,s largest ice sheets ... same in our modern, progressively warming world. , However, ...
Breaking Biology News(10 mins):SUMO wrestling cells reveal new protective mechanism target for stroke 2New X-ray method shows how frog embryos could help thwart disease 2World's biggest ice sheets likely more stable than previously believed 2
... Technological University (NTU), and Israel,s number one university, ... new collaboration to jointly offer a Doctor of ... PhD degree programme is a university-wide agreement and ... Bioengineering. Significantly, the joint PhD degree will also ...
... the study and manipulation of human embryonic stem cells ... competition for a Hebrew University of Jerusalem researcher. ... Benvenisty of the Silberman Institute of Life Sciences was ... the Hebrew University of Jerusalem Board of Governors 73rd ...
... Guam,s territorial entomologist and Aubrey Moore, UOG extension entomologist, ... early June. Jackson was invited to assist in ... (Oryctes rhinoceros) population. This virus only infects rhino ... of the pest on other Pacific islands. The ...
Cached Biology News:NTU ramps up collaboration with Israel's top university 2NTU ramps up collaboration with Israel's top university 3Research on stem cells wins first prize for Hebrew University researcher 2Research on stem cells wins first prize for Hebrew University researcher 3Unusual rhino beetle behavior discovered 2